Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Abroad (travel likely)RecruitingPHASE3

Conditions

Endometrial Carcinoma · Endometrial Clear Cell Adenocarcinoma · Endometrial Dedifferentiated Carcinoma · Endometrial Endometrioid Adenocarcinoma · Endometrial Mixed Cell Adenocarcinoma · Endometrial Serous Adenocarcinoma · Endometrial Undifferentiated Carcinoma · Uterine Corpus Malignant Mixed Mesodermal (Mullerian) Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States

    Contact: Study coordinator (Site Public Contact) · gingerreeves@uabmc.edu
    Contact: Principal Investigator (Michael D. Toboni)
  • Alaska Women's Cancer Care, Anchorage, Alaska, United States

    Contact: Study coordinator (Site Public Contact) · AKPAMC.OncologyResearchSupport@providence.org · 907-212-6871
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Banner University Medical Center - Tucson, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · UACC-IIT@uacc.arizona.edu
    Contact: Principal Investigator (Setsuko K. Chambers)
  • University of Arizona Cancer Center-North Campus, Tucson, Arizona, United States

    Contact: Study coordinator (Site Public Contact) · UACC-IIT@uacc.arizona.edu
    Contact: Principal Investigator (Setsuko K. Chambers)
  • University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

    Contact: Study coordinator (Site Public Contact) · 501-686-8274
    Contact: Principal Investigator (Heather R. Williams)
  • Sutter Auburn Faith Hospital, Auburn, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (John K. Chan)
  • Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (John K. Chan)
  • John Muir Medical Center-Concord, Concord, California, United States

  • City of Hope Comprehensive Cancer Center, Duarte, California, United States

  • City of Hope Seacliff, Huntington Beach, California, United States

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Krishnansu S. Tewari)
  • City of Hope at Irvine Lennar, Irvine, California, United States

  • Kaiser Permanente-Irvine, Irvine, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Scott E. Lentz)
  • City of Hope at Long Beach Elm, Long Beach, California, United States

  • Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Scott E. Lentz)
  • Memorial Medical Center, Modesto, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (John K. Chan)
  • Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (John K. Chan)
  • Saint Joseph Hospital - Orange, Orange, California, United States

    Contact: Study coordinator (Site Public Contact) · 714-734-6220
    Contact: Principal Investigator (Madhavi Mummaneni)
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States

    Contact: Study coordinator (Site Public Contact) · ucstudy@uci.edu · 877-827-8839
    Contact: Principal Investigator (Krishnansu S. Tewari)
  • Stanford Cancer Institute Palo Alto, Palo Alto, California, United States

    Contact: Study coordinator (Site Public Contact) · ccto-office@stanford.edu · 650-498-7061
    Contact: Principal Investigator (Kristin L. Bixel)
  • Kaiser Permanente - Panorama City, Panorama City, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Scott E. Lentz)
  • Kaiser Permanente-Riverside, Riverside, California, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@kp.org · 800-398-3996
    Contact: Principal Investigator (Scott E. Lentz)
  • Sutter Roseville Medical Center, Roseville, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (John K. Chan)
  • Sutter Medical Center Sacramento, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (John K. Chan)
  • University of California Davis Comprehensive Cancer Center, Sacramento, California, United States

    Contact: Study coordinator (Site Public Contact) · 916-734-3089
    Contact: Principal Investigator (Rebecca A. Brooks)
  • California Pacific Medical Center-Pacific Campus, San Francisco, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (John K. Chan)
  • Palo Alto Medical Foundation-Santa Cruz, Santa Cruz, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (John K. Chan)
  • Palo Alto Medical Foundation-Sunnyvale, Sunnyvale, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@sutterhealth.org
    Contact: Principal Investigator (John K. Chan)
  • City of Hope Upland, Upland, California, United States

  • John Muir Medical Center-Walnut Creek, Walnut Creek, California, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@johnmuirhealth.com · 925-941-4246
    Contact: Principal Investigator (Babak Edraki)
  • UCHealth University of Colorado Hospital, Aurora, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 720-848-0650
    Contact: Principal Investigator (Marisa R. Moroney)
  • UCHealth - Cherry Creek, Denver, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Marisa R. Moroney)
  • AdventHealth Porter, Denver, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · research.institute@adventhealth.com
    Contact: Principal Investigator (Neil T. Phippen)
  • Grand Valley Oncology, Grand Junction, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · gvoclinicaltrials@gjhosp.org · 970-644-4460
    Contact: Principal Investigator (Jonathan D. King)
  • Banner North Colorado Medical Center, Greeley, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · BMDACCResearchCOMailbox@bannerhealth.com · 970-810-3046
    Contact: Principal Investigator (Robin A. Lacour)
  • UCHealth Highlands Ranch Hospital, Highlands Ranch, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · 720-848-0650
    Contact: Principal Investigator (Marisa R. Moroney)
  • Banner North Colorado Medical Center - Loveland Campus, Loveland, Colorado, United States

    Contact: Study coordinator (Site Public Contact) · BMDACCResearchCOMailbox@bannerhealth.com · 970-810-3046
    Contact: Principal Investigator (Robin A. Lacour)
  • Danbury Hospital, Danbury, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · 833-223-4732
    Contact: Principal Investigator (Wenli Gao)
  • Smilow Cancer Hospital-Derby Care Center, Derby, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Alessandro D. Santin)
  • Smilow Cancer Hospital Care Center-Fairfield, Fairfield, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Alessandro D. Santin)
  • Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Alessandro D. Santin)
  • Smilow Cancer Hospital Care Center at Greenwich, Greenwich, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Alessandro D. Santin)
  • Smilow Cancer Hospital Care Center - Guilford, Guilford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Alessandro D. Santin)
  • Smilow Cancer Hospital Care Center at Saint Francis, Hartford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Alessandro D. Santin)
  • Yale University, New Haven, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Alessandro D. Santin)
  • Yale-New Haven Hospital North Haven Medical Center, North Haven, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Alessandro D. Santin)
  • Norwalk Hospital, Norwalk, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · jennifer.long@norwalkhealth.org · 203-852-2996
    Contact: Principal Investigator (Richard C. Frank)
  • Smilow Cancer Hospital Care Center at Long Ridge, Stamford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Alessandro D. Santin)
  • Smilow Cancer Hospital-Torrington Care Center, Torrington, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Alessandro D. Santin)
  • Smilow Cancer Hospital Care Center-Trumbull, Trumbull, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Alessandro D. Santin)
  • Smilow Cancer Hospital-Waterbury Care Center, Waterbury, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Alessandro D. Santin)
  • Smilow Cancer Hospital Care Center - Waterford, Waterford, Connecticut, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Alessandro D. Santin)
  • Helen F Graham Cancer Center, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Medical Oncology Hematology Consultants PA, Newark, Delaware, United States

    Contact: Study coordinator (Site Public Contact) · lbarone@christianacare.org · 302-623-4450
    Contact: Principal Investigator (Gregory A. Masters)
  • Sibley Memorial Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · jquiver1@jhmi.edu · 202-243-2373
    Contact: Principal Investigator (Amanda N. Fader)
  • George Washington University Medical Center, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Site Public Contact) · 202-741-2210
    Contact: Principal Investigator (Micael Lopez Acevedo)
  • Broward Health Medical Center, Fort Lauderdale, Florida, United States

    Contact: Study coordinator (Site Public Contact) · Allison.bruce@nemours.org · 302-651-5572
    Contact: Principal Investigator (Scott E. Jordan)
  • Jupiter Medical Center, Jupiter, Florida, United States

  • Sarasota Memorial Hospital-Venice, N. Venice, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 941-261-9000
    Contact: Principal Investigator (Beverly Long)
  • AdventHealth Orlando, Orlando, Florida, United States

    Contact: Study coordinator (Site Public Contact) · FH.Cancer.Research@flhosp.org · 407-303-2090
    Contact: Principal Investigator (Nathalie D. McKenzie)
  • First Physicians Group-Sarasota, Sarasota, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 941-917-8383
    Contact: Principal Investigator (Beverly Long)
  • Florida Cancer Specialists - Sarasota Downtown, Sarasota, Florida, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@FLCancer.com · 239-274-9930
    Contact: Principal Investigator (Beverly Long)
  • Sarasota Memorial Hospital, Sarasota, Florida, United States

    Contact: Study coordinator (Site Public Contact) · 941-917-2225
    Contact: Principal Investigator (Beverly Long)
  • Florida Cancer Specialists - Venice Pinebrook, Venice, Florida, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalTrials@FLCancer.com · 239-274-9930
    Contact: Principal Investigator (Beverly Long)
  • Grady Health System, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-778-1868
    Contact: Principal Investigator (Namita Khanna)
  • Emory University Hospital Midtown, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 888-946-7447
    Contact: Principal Investigator (Namita Khanna)
  • Piedmont Hospital, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · ORS@piedmont.org · 404-425-7943
    Contact: Principal Investigator (Leda Portia A. Gattoc)
  • Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-778-1868
    Contact: Principal Investigator (Namita Khanna)
  • Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · 404-851-7115
    Contact: Principal Investigator (Namita Khanna)
  • Augusta University Medical Center, Augusta, Georgia, United States

  • Emory Decatur Hospital, Decatur, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrialsoncology@dekalbmedical.org · 440-778-1868
    Contact: Principal Investigator (Namita Khanna)
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah, Georgia, United States

    Contact: Study coordinator (Site Public Contact) · underberga@sjchs.org · 912-819-5704
    Contact: Principal Investigator (Sarah E. Gill)
  • Queen's Medical Center, Honolulu, Hawaii, United States

  • Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, United States

  • Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · stephanie.couch@stjoeshealth.org · 734-712-3671
    Contact: Principal Investigator (J. R. Liu)
  • Saint Luke's Cancer Institute - Boise, Boise, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · eslinget@slhs.org · 208-381-2774
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Saint Alphonsus Cancer Care Center-Caldwell, Caldwell, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · stephanie.couch@stjoeshealth.org · 734-712-3671
    Contact: Principal Investigator (J. R. Liu)
  • Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Saint Luke's Cancer Institute - Fruitland, Fruitland, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · eslinget@slhs.org · 208-381-2774
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Saint Luke's Cancer Institute - Meridian, Meridian, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · eslinget@slhs.org · 208-381-2774
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Saint Alphonsus Cancer Care Center-Nampa, Nampa, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (J. R. Liu)
  • Saint Luke's Cancer Institute - Nampa, Nampa, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · eslinget@slhs.org · 208-381-2774
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Kootenai Clinic Cancer Services - Sandpoint, Sandpoint, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Saint Luke's Cancer Institute - Twin Falls, Twin Falls, Idaho, United States

    Contact: Study coordinator (Site Public Contact) · eslinget@slhs.org · 208-381-2774
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Northwest Community Hospital, Arlington Heights, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-618-4968
    Contact: Principal Investigator (Kathryn A. Mills)
  • Rush-Copley Medical Center, Aurora, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · RCMC_Cancer_Research@rush.edu · 630-978-6212
    Contact: Principal Investigator (Pratima Chalasani)
  • Centralia Oncology Clinic, Centralia, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern University, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancer@northwestern.edu · 312-695-1301
    Contact: Principal Investigator (Emily Hinchcliff)
  • John H Stroger Jr Hospital of Cook County, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 312-864-5204
    Contact: Principal Investigator (Deimante M. Tamkus)
  • Rush MD Anderson Cancer Center, Chicago, Illinois, United States

  • University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Katherine C. Kurnit)
  • Carle at The Riverfront, Danville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Pratima Chalasani)
  • Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Decatur Memorial Hospital, Decatur, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Cancer Center Kishwaukee, DeKalb, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Emily Hinchcliff)
  • Carle Physician Group-Effingham, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Pratima Chalasani)
  • Crossroads Cancer Center, Effingham, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • NorthShore University HealthSystem-Evanston Hospital, Evanston, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-570-2109
    Contact: Principal Investigator (Mary T. Jenkins Vogel)
  • Northwestern Medicine Cancer Center Delnor, Geneva, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Emily Hinchcliff)
  • NorthShore University HealthSystem-Glenbrook Hospital, Glenview, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-570-2109
    Contact: Principal Investigator (Mary T. Jenkins Vogel)
  • Northwestern Medicine Glenview Outpatient Center, Glenview, Illinois, United States

  • Northwestern Medicine Grayslake Outpatient Center, Grayslake, Illinois, United States

  • Ingalls Memorial Hospital, Harvey, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@ingalls.org · 708-915-4673
    Contact: Principal Investigator (Ivy Abraham)
  • NorthShore University HealthSystem-Highland Park Hospital, Highland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 847-570-2109
    Contact: Principal Investigator (Mary T. Jenkins Vogel)
  • Sudarshan K Sharma MD Limited-Gynecologic Oncology, Hinsdale, Illinois, United States

  • Northwestern Medicine Lake Forest Hospital, Lake Forest, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancertrials@northwestern.edu
    Contact: Principal Investigator (Emily Hinchcliff)
  • Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Pratima Chalasani)
  • UC Comprehensive Cancer Center at Silver Cross, New Lenox, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Katherine C. Kurnit)
  • Carle Cancer Institute Normal, Normal, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@Carle.com · 800-446-5532
    Contact: Principal Investigator (Pratima Chalasani)
  • Cancer Care Center of O'Fallon, O'Fallon, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · morganthaler.jodi@mhsil.com · 217-876-4762
    Contact: Principal Investigator (Bryan A. Faller)
  • Northwestern Medicine Orland Park, Orland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · nctnprogram_rhlccc@northwestern.edu
    Contact: Principal Investigator (Emily Hinchcliff)
  • University of Chicago Medicine-Orland Park, Orland Park, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 773-702-8222
    Contact: Principal Investigator (Katherine C. Kurnit)
  • UW Health Carbone Cancer Center Rockford, Rockford, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · lkline@uwhealth.org · 779-696-9378
    Contact: Principal Investigator (Fahrettin Covut)
  • Southern Illinois University School of Medicine, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 217-545-7929
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Clinic, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · 800-444-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Springfield Memorial Hospital, Springfield, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · pallante.beth@mhsil.com · 217-528-7541
    Contact: Principal Investigator (Bryan A. Faller)
  • Carle Cancer Center, Urbana, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Research@carle.com · 800-446-5532
    Contact: Principal Investigator (Pratima Chalasani)
  • Northwestern Medicine Cancer Center Warrenville, Warrenville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Donald.Smith3@nm.org · 630-352-5360
    Contact: Principal Investigator (Emily Hinchcliff)
  • Rush-Copley Healthcare Center, Yorkville, Illinois, United States

    Contact: Study coordinator (Site Public Contact) · Cancer.Research@rushcopley.com · 630-978-6212
    Contact: Principal Investigator (Pratima Chalasani)
  • IU Health North Hospital, Carmel, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · iutrials@iu.edu · 317-278-5632
    Contact: Principal Investigator (Jessica E. Parker)
  • Northwest Cancer Center - Crown Point, Crown Point, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · CancerResearch@powershealth.org · 219-836-6879
    Contact: Principal Investigator (Pratima Chalasani)
  • UChicago Medicine Northwest Indiana, Crown Point, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@bsd.uchicago.edu · 855-702-8222
    Contact: Principal Investigator (Katherine C. Kurnit)
  • Northwest Oncology LLC, Dyer, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · 219-924-8178
    Contact: Principal Investigator (Pratima Chalasani)
  • Goshen Center for Cancer Care, Goshen, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · cccois@goshenhealth.com · 574-364-2973
    Contact: Principal Investigator (Pamela J. Stone)
  • Northwest Cancer Center - Hobart, Hobart, Indiana, United States

  • Saint Mary Medical Center, Hobart, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · CancerResearch@COMHS.org · 219-836-6875
    Contact: Principal Investigator (Pratima Chalasani)
  • Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · iutrials@iu.edu · 317-278-5632
    Contact: Principal Investigator (Jessica E. Parker)
  • Franciscan Health Indianapolis, Indianapolis, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · 317-528-7060
    Contact: Principal Investigator (Harsha Ranganath)
  • Ascension Saint Vincent Indianapolis Hospital, Indianapolis, Indiana, United States

  • Saint Catherine Hospital, Indianapolis, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Pratima Chalasani)
  • Franciscan Saint Elizabeth Health - Lafayette East, Lafayette, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · ctsucontact@westat.com · 888-823-5923
    Contact: Principal Investigator (Harsha Ranganath)
  • Franciscan Health Mooresville, Mooresville, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · 317-834-3603
    Contact: Principal Investigator (Harsha Ranganath)
  • The Community Hospital, Munster, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · 219-836-3349
    Contact: Principal Investigator (Pratima Chalasani)
  • Women's Diagnostic Center - Munster, Munster, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · mnicholson@comhs.org · 219-934-8869
    Contact: Principal Investigator (Pratima Chalasani)
  • Memorial Hospital of South Bend, South Bend, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · 800-284-7370
    Contact: Principal Investigator (LaToya J. Perry)
  • Northwest Cancer Center - Valparaiso, Valparaiso, Indiana, United States

    Contact: Study coordinator (Site Public Contact) · CancerResearch@COMHS.org · 219-836-6875
    Contact: Principal Investigator (Pratima Chalasani)
  • Mary Greeley Medical Center, Ames, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • McFarland Clinic - Ames, Ames, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · ksoder@mcfarlandclinic.com · 515-239-4734
    Contact: Principal Investigator (Joseph J. Merchant)
  • McFarland Clinic - Boone, Boone, Iowa, United States

  • Heartland Oncology and Hematology LLP, Council Bluffs, Iowa, United States

  • Nebraska Cancer Specialists/Oncology Hematology West PC - MEJ, Council Bluffs, Iowa, United States

  • McFarland Clinic - Trinity Cancer Center, Fort Dodge, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 800-237-1225
    Contact: Principal Investigator (David P. Bender)
  • McFarland Clinic - Jefferson, Jefferson, Iowa, United States

  • McFarland Clinic - Marshalltown, Marshalltown, Iowa, United States

    Contact: Study coordinator (Site Public Contact) · 515-956-4132
    Contact: Principal Investigator (Joseph J. Merchant)
  • Saint Elizabeth Healthcare Edgewood, Edgewood, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · Kristi.Curtsinger@stelizabeth.com · 859-301-4730
    Contact: Principal Investigator (Rachel Bramblet)
  • Baptist Health Lexington, Lexington, Kentucky, United States

    Contact: Study coordinator (Site Public Contact) · 859-260-6425
    Contact: Principal Investigator (Hope Cottrill)
  • Baptist Health Louisville, Louisville, Kentucky, United States

  • LSU Health Baton Rouge-North Clinic, Baton Rouge, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · research@ololrmc.com · 225-765-7659
    Contact: Principal Investigator (Marshall P. Stagg)
  • Our Lady of the Lake Physician Group, Baton Rouge, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · research@ololrmc.com · 225-765-7659
    Contact: Principal Investigator (Marshall P. Stagg)
  • Our Lady of the Lake Medical Oncology, Baton Rouge, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · research@ololrmc.com · 225-765-7659
    Contact: Principal Investigator (Marshall P. Stagg)
  • Ochsner Hematology Oncology North Shore - Covington (West Region), Covington, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · Cheryl.kesler@ochsner.org · 985-809-5668
    Contact: Principal Investigator (Chad A. Hamilton)
  • West Jefferson Medical Center, Marrero, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · emede1@lsuhsc.edu · 504-210-3539
    Contact: Principal Investigator (Tara Castellano)
  • East Jefferson General Hospital, Metairie, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · emede1@lsuhsc.edu · 504-210-3539
    Contact: Principal Investigator (Tara Castellano)
  • LSU Healthcare Network / Metairie Multi-Specialty Clinic, Metairie, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · emede1@lsuhsc.edu · 504-210-3539
    Contact: Principal Investigator (Tara Castellano)
  • University Medical Center New Orleans, New Orleans, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · emede1@lsuhsc.edu · 504-210-3539
    Contact: Principal Investigator (Tara Castellano)
  • Ochsner Baptist Medical Center, New Orleans, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · Elisemarie.curry@ochsner.org · 504-842-8084
    Contact: Principal Investigator (Chad A. Hamilton)
  • Ochsner Medical Center Jefferson, New Orleans, Louisiana, United States

    Contact: Study coordinator (Site Public Contact) · Elisemarie.curry@ochsner.org · 504-842-8084
    Contact: Principal Investigator (Chad A. Hamilton)
  • Harold Alfond Center for Cancer Care, Augusta, Maine, United States

    Contact: Study coordinator (Site Public Contact) · 207-626-4855
    Contact: Principal Investigator (Leslie S. Bradford)
  • MaineHealth Maine Medical Center- Scarborough, Scarborough, Maine, United States

    Contact: Study coordinator (Site Public Contact) · clinicalresearch@mainehealth.org · 207-396-8670
    Contact: Principal Investigator (Leslie S. Bradford)
  • Greater Baltimore Medical Center, Baltimore, Maryland, United States

  • Sinai Hospital of Baltimore, Baltimore, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · 410-601-9083
    Contact: Principal Investigator (Pallavi P. Kumar)
  • MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore, Maryland, United States

  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · jhcccro@jhmi.edu · 410-955-8804
    Contact: Principal Investigator (Amanda N. Fader)
  • Walter Reed National Military Medical Center, Bethesda, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · 301-319-2100
    Contact: Principal Investigator (Christopher Tarney)
  • William E Kahlert Regional Cancer Center/Sinai Hospital, Westminster, Maryland, United States

    Contact: Study coordinator (Site Public Contact) · 410-871-6400
    Contact: Principal Investigator (Pallavi P. Kumar)
  • Baystate Medical Center, Springfield, Massachusetts, United States

    Contact: Study coordinator (Site Public Contact) · tamara.wrenn@baystatehealth.org · 413-794-3565
    Contact: Principal Investigator (Tashanna K. Myers)
  • University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · CancerAnswerLine@med.umich.edu · 800-865-1125
    Contact: Principal Investigator (Zhen Ni Zhou)
  • Bronson Battle Creek, Battle Creek, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (J. R. Liu)
  • Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (J. R. Liu)
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (J. R. Liu)
  • Wayne State University/Karmanos Cancer Institute, Detroit, Michigan, United States

  • Weisberg Cancer Treatment Center, Farmington Hills, Michigan, United States

  • Corewell Health Farmington Hills Hospital, Farmington Hills, Michigan, United States

  • Cancer Hematology Centers - Flint, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (J. R. Liu)
  • Genesee Hematology Oncology PC, Flint, Michigan, United States

  • Genesys Hurley Cancer Institute, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (J. R. Liu)
  • Hurley Medical Center, Flint, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · wstrong@ghci.org · 810-762-8038
    Contact: Principal Investigator (J. R. Liu)
  • Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Trinity Health Grand Rapids Hospital, Grand Rapids, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Bronson Methodist Hospital, Kalamazoo, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • West Michigan Cancer Center, Kalamazoo, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Beacon Kalamazoo Cancer Center, Kalamazoo, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 574-647-7370
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Trinity Health Saint Mary Mercy Livonia Hospital, Livonia, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (J. R. Liu)
  • Trinity Health Muskegon Hospital, Muskegon, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Corewell Health Lakeland Hospitals - Niles Hospital, Niles, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Cancer and Hematology Centers of Western Michigan - Norton Shores, Norton Shores, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · connie.szczepanek@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (J. R. Liu)
  • Corewell Health Reed City Hospital, Reed City, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, United States

  • MyMichigan Medical Center Saginaw, Saginaw, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (J. R. Liu)
  • Oncology Hematology Associates of Saginaw Valley PC, Saginaw, Michigan, United States

  • Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center, Saint Joseph, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Corewell Health Lakeland Hospitals - Saint Joseph Hospital, Saint Joseph, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • MyMichigan Medical Center Tawas, Tawas City, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (J. R. Liu)
  • Munson Medical Center, Traverse City, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Corewell Health Beaumont Troy Hospital, Troy, Michigan, United States

  • Saint Mary's Oncology/Hematology Associates of West Branch, West Branch, Michigan, United States

  • University of Michigan Health - West, Wyoming, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · crcwm-regulatory@crcwm.org · 616-391-1230
    Contact: Principal Investigator (Kathleen Y. Butler)
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti, Michigan, United States

    Contact: Study coordinator (Site Public Contact) · MCRCwebsitecontactform@stjoeshealth.org · 734-712-7251
    Contact: Principal Investigator (J. R. Liu)
  • Mercy Hospital, Coon Rapids, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Jessica A. Thomes Pepin)
  • Fairview Southdale Hospital, Edina, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Jessica A. Thomes Pepin)
  • Minnesota Oncology - Edina, Edina, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Jessica A. Thomes Pepin)
  • Minnesota Oncology Hematology PA-Maplewood, Maplewood, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Jessica A. Thomes Pepin)
  • Avera Cancer Institute at Marshall, Marshall, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · OncRegulatory@avera.org · 605-322-3095
    Contact: Principal Investigator (David C. Starks)
  • Abbott-Northwestern Hospital, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Jessica A. Thomes Pepin)
  • University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · 612-624-2620
    Contact: Principal Investigator (Britt K. Erickson)
  • Park Nicollet Clinic - Saint Louis Park, Saint Louis Park, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Jessica A. Thomes Pepin)
  • Regions Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Jessica A. Thomes Pepin)
  • United Hospital, Saint Paul, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Jessica A. Thomes Pepin)
  • Minnesota Oncology Hematology PA-Woodbury, Woodbury, Minnesota, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Jessica A. Thomes Pepin)
  • MU Health - University Hospital/Ellis Fischel Cancer Center, Columbia, Missouri, United States

  • Phelps Health Delbert Day Cancer Institute, Rolla, Missouri, United States

  • CoxHealth South Hospital, Springfield, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 417-269-4520
    Contact: Principal Investigator (Jay W. Carlson)
  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · info@siteman.wustl.edu · 800-600-3606
    Contact: Principal Investigator (Premal H. Thaker)
  • Mercy Hospital South, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · Danielle.Werle@mercy.net · 314-525-6042
    Contact: Principal Investigator (Jay W. Carlson)
  • Mercy Hospital Saint Louis, St Louis, Missouri, United States

    Contact: Study coordinator (Site Public Contact) · 314-251-7066
    Contact: Principal Investigator (Jay W. Carlson)
  • Community Hospital of Anaconda, Anaconda, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Billings Clinic Cancer Center, Billings, Montana, United States

    Contact: Study coordinator (Site Public Contact) · research@billingsclinic.org · 800-996-2663
    Contact: Principal Investigator (John M. Schallenkamp)
  • Saint Vincent Frontier Cancer Center, Billings, Montana, United States

    Contact: Study coordinator (Site Public Contact) · 800-648-6274
    Contact: Principal Investigator (Patrick W. Cobb)
  • Intermountain Health West End Clinic, Billings, Montana, United States

    Contact: Study coordinator (Site Public Contact) · 406-238-6685
    Contact: Principal Investigator (Patrick W. Cobb)
  • Bozeman Health Deaconess Hospital, Bozeman, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Benefis Sletten Cancer Institute, Great Falls, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Logan Health Medical Center, Kalispell, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Saint Patrick Hospital - Community Hospital, Missoula, Montana, United States

    Contact: Study coordinator (Site Public Contact) · amy.hanneman@providence.org · 406-327-3118
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Community Medical Center, Missoula, Montana, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (John M. Schallenkamp)
  • Nebraska Cancer Specialists/Oncology Hematology West PC - MECC, Omaha, Nebraska, United States

  • Nebraska Methodist Hospital, Omaha, Nebraska, United States

    Contact: Study coordinator (Site Public Contact) · 402-354-5144
    Contact: Principal Investigator (Brent J. Tierney)
  • Alegent Health Bergan Mercy Medical Center, Omaha, Nebraska, United States

  • University of Nebraska Medical Center, Omaha, Nebraska, United States

  • OptumCare Cancer Care at Charleston, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Women's Cancer Center of Nevada, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · 702-851-4672
    Contact: Principal Investigator (Nicola M. Spirtos)
  • OptumCare Cancer Care at Fort Apache, Las Vegas, Nevada, United States

    Contact: Study coordinator (Site Public Contact) · research@sncrf.org · 702-384-0013
    Contact: Principal Investigator (John A. Ellerton)
  • Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Carol Aghajanian)
  • Cooper Hospital University Medical Center, Camden, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 856-325-6757
    Contact: Principal Investigator (David P. Warshal)
  • Hackensack University Medical Center, Hackensack, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 551-996-2897
    Contact: Principal Investigator (Donna M. McNamara)
  • Monmouth Medical Center Southern Campus, Lakewood, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · mary.danish@rwjbh.org · 732-923-6564
    Contact: Principal Investigator (Eugenia Girda)
  • Saint Barnabas Medical Center, Livingston, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · joanne.loeb@rwjbh.org · 973-322-2934
    Contact: Principal Investigator (Eugenia Girda)
  • Monmouth Medical Center, Long Branch, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · mary.danish@rwjbh.org · 732-923-6564
    Contact: Principal Investigator (Eugenia Girda)
  • Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Carol Aghajanian)
  • Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Carol Aghajanian)
  • Virtua Samson Cancer Center, Moorestown, New Jersey, United States

  • Jersey Shore Medical Center, Neptune City, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 732-776-4240
    Contact: Principal Investigator (Karim S. ElSahwi)
  • Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 732-235-7356
    Contact: Principal Investigator (Eugenia Girda)
  • Rutgers New Jersey Medical School, Newark, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 732-235-7356
    Contact: Principal Investigator (Eugenia Girda)
  • Riverview Medical Center/Booker Cancer Center, Red Bank, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · 732-530-2382
    Contact: Principal Investigator (Karim S. ElSahwi)
  • Sidney Kimmel Cancer Center Washington Township, Sewell, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Mitchell I. Edelson)
  • Robert Wood Johnson University Hospital Somerset, Somerville, New Jersey, United States

  • Community Medical Center, Toms River, New Jersey, United States

    Contact: Study coordinator (Site Public Contact) · Lennette.Gonzales@rwjbh.org · 732-557-8294
    Contact: Principal Investigator (Eugenia Girda)
  • Virtua Voorhees, Voorhees Township, New Jersey, United States

  • University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

    Contact: Study coordinator (Site Public Contact) · HSC-ClinicalTrialInfo@salud.unm.edu · 505-925-0348
    Contact: Principal Investigator (Carolyn Y. Muller)
  • Presbyterian Kaseman Hospital, Albuquerque, New Mexico, United States

  • Presbyterian Rust Medical Center/Jorgensen Cancer Center, Rio Rancho, New Mexico, United States

  • Women's Cancer Care Associates LLC, Albany, New York, United States

    Contact: Study coordinator (Site Public Contact) · jbarlin@womenscancercareassociates.com · 518-458-1390
    Contact: Principal Investigator (Peter J. Frederick)
  • Memorial Sloan Kettering Commack, Commack, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Carol Aghajanian)
  • Memorial Sloan Kettering Westchester, Harrison, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Carol Aghajanian)
  • NYU Langone Hospital - Long Island, Mineola, New York, United States

    Contact: Study coordinator (Site Public Contact) · cancertrials@nyulangone.org · 212-263-4432
    Contact: Principal Investigator (Whitfield B. Growdon)
  • Mount Sinai Chelsea, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · CCTO@mssm.edu · 212-824-7309
    Contact: Principal Investigator (Stephanie V. Blank)
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · CancerTrials@nyulangone.org
    Contact: Principal Investigator (Whitfield B. Growdon)
  • Mount Sinai Hospital, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · CCTO@mssm.edu · 212-824-7309
    Contact: Principal Investigator (Stephanie V. Blank)
  • Memorial Sloan Kettering Cancer Center, New York, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Carol Aghajanian)
  • University of Rochester, Rochester, New York, United States

    Contact: Study coordinator (Site Public Contact) · 585-275-5830
    Contact: Principal Investigator (Richard G. Moore)
  • State University of New York Upstate Medical University, Syracuse, New York, United States

    Contact: Study coordinator (Site Public Contact) · 315-464-5476
    Contact: Principal Investigator (Mary J. Cunningham)
  • Memorial Sloan Kettering Nassau, Uniondale, New York, United States

    Contact: Study coordinator (Site Public Contact) · 212-639-7592
    Contact: Principal Investigator (Carol Aghajanian)
  • Wilmot Cancer Institute at Webster, Webster, New York, United States

    Contact: Study coordinator (Site Public Contact) · WCICTOresearch@urmc.rochester.edu
    Contact: Principal Investigator (Richard G. Moore)
  • Duke Cancer Center Cary, Cary, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · NCTNStudyTeam@dm.duke.edu
    Contact: Principal Investigator (Angeles A. Secord)
  • UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · cancerclinicaltrials@med.unc.edu · 877-668-0683
    Contact: Principal Investigator (Linda Van Le)
  • Duke University Medical Center, Durham, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 888-275-3853
    Contact: Principal Investigator (Angeles A. Secord)
  • ECU Health Medical Center, Greenville, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · research@ecuhealth.org · 252-744-2391
    Contact: Principal Investigator (Jhalak Dholakia)
  • Hayworth Cancer Center, High Point, North Carolina, United States

  • Duke Women's Cancer Care Raleigh, Raleigh, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 919-785-4878
    Contact: Principal Investigator (Angeles A. Secord)
  • Novant Health New Hanover Regional Medical Center, Wilmington, North Carolina, United States

    Contact: Study coordinator (Site Public Contact) · 910-342-3000
    Contact: Principal Investigator (Lucybeth Nieves-Arriba)
  • Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

  • Sanford Bismarck Medical Center, Bismarck, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Maria C. Bell)
  • Sanford Broadway Medical Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-323-5760
    Contact: Principal Investigator (Maria C. Bell)
  • Sanford Roger Maris Cancer Center, Fargo, North Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsFargo@sanfordhealth.org · 701-234-6161
    Contact: Principal Investigator (Maria C. Bell)
  • UHHS-Chagrin Highlands Medical Center, Beachwood, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Amy Armstrong)
  • Strecker Cancer Center-Belpre, Belpre, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Aultman Health Foundation, Canton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · ClinicalReserachDept@aultman.com · 330-363-7274
    Contact: Principal Investigator (Raza A. Khan)
  • Miami Valley Hospital South, Centerville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Michael S. Guy)
  • Geauga Hospital, Chardon, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Amy Armstrong)
  • Adena Regional Medical Center, Chillicothe, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 877-779-7585
    Contact: Principal Investigator (Aruna C. Gowda)
  • Good Samaritan Hospital - Cincinnati, Cincinnati, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · ResearchInstituteInquiries@CommonSpirit.org · 720-874-1881
    Contact: Principal Investigator (Shahzad Siddique)
  • Case Western Reserve University, Cleveland, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Amy Armstrong)
  • MetroHealth Medical Center, Cleveland, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · ababal@metrohealth.org · 216-778-7559
    Contact: Principal Investigator (Kimberly E. Resnick)
  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jamesline@osumc.edu · 800-293-5066
    Contact: Principal Investigator (Casey Cosgrove)
  • Mount Carmel East Hospital, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Riverside Methodist Hospital, Columbus, Ohio, United States

  • The Mark H Zangmeister Center, Columbus, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Miami Valley Hospital, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Michael S. Guy)
  • Miami Valley Hospital North, Dayton, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Michael S. Guy)
  • Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Michael S. Guy)
  • Miami Valley Cancer Care and Infusion, Greenville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · 937-569-7515
    Contact: Principal Investigator (Michael S. Guy)
  • Mount Carmel Grove City Hospital, Grove City, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Fairfield Medical Center, Lancaster, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Saint Rita's Medical Center, Lima, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Marietta Memorial Hospital, Marietta, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Memorial Hospital, Marysville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • UH Seidman Cancer Center at Lake Health Mentor Campus, Mentor, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Amy Armstrong)
  • Knox Community Hospital, Mount Vernon, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Licking Memorial Hospital, Newark, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • University Hospitals Parma Medical Center, Parma, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Amy Armstrong)
  • Mercy Health - Perrysburg Hospital, Perrysburg, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Southern Ohio Medical Center, Portsmouth, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Springfield Regional Cancer Center, Springfield, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Springfield Regional Medical Center, Springfield, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • ProMedica Flower Hospital, Sylvania, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · PCIOncResearch@promedica.org · 419-824-1842
    Contact: Principal Investigator (Kathleen G. Essel)
  • Mercy Health - Saint Vincent Hospital, Toledo, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Mercy Health - Saint Anne Hospital, Toledo, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • Upper Valley Medical Center, Troy, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · clinical.trials@daytonncorp.org · 937-528-2900
    Contact: Principal Investigator (Michael S. Guy)
  • Saint Ann's Hospital, Westerville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • UH Seidman Cancer Center at Saint John Medical Center, Westlake, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · CTUReferral@UHhospitals.org · 800-641-2422
    Contact: Principal Investigator (Amy Armstrong)
  • Genesis Healthcare System Cancer Care Center, Zanesville, Ohio, United States

    Contact: Study coordinator (Site Public Contact) · Jeffh@columbusccop.org · 614-488-2745
    Contact: Principal Investigator (Aruna C. Gowda)
  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · ou-clinical-trials@ouhsc.edu · 405-271-8777
    Contact: Principal Investigator (Lauren E. Dockery)
  • Mercy Hospital Oklahoma City, Oklahoma City, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · 405-752-3402
    Contact: Principal Investigator (Jay W. Carlson)
  • Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa, Oklahoma, United States

    Contact: Study coordinator (Site Public Contact) · 918-505-3200
    Contact: Principal Investigator (Katherine M. Moxley)
  • Providence Cancer Institute Clackamas Clinic, Clackamas, Oregon, United States

  • Providence Newberg Medical Center, Newberg, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Saint Alphonsus Cancer Care Center-Ontario, Ontario, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · mccinfo@mtcancer.org · 406-969-6060
    Contact: Principal Investigator (J. R. Liu)
  • Legacy Good Samaritan Hospital and Medical Center, Portland, Oregon, United States

  • Providence Portland Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Providence Saint Vincent Medical Center, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · CanRsrchStudies@providence.org · 503-215-2614
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Oregon Health and Science University, Portland, Oregon, United States

    Contact: Study coordinator (Site Public Contact) · trials@ohsu.edu · 503-494-1080
    Contact: Principal Investigator (Jessica Jou)
  • Legacy Meridian Park Hospital, Tualatin, Oregon, United States

  • Lehigh Valley Hospital-Cedar Crest, Allentown, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (J. R. Liu)
  • Saint Luke's Cancer Center - Allentown, Allentown, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 610-776-4714
    Contact: Principal Investigator (Nicholas P. Taylor)
  • Saint Luke's University Hospital-Bethlehem Campus, Bethlehem, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 484-503-4151
    Contact: Principal Investigator (Nicholas P. Taylor)
  • Lehigh Valley Hospital - Muhlenberg, Bethlehem, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (J. R. Liu)
  • Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · turzoe@mlhs.org · 484-476-2649
    Contact: Principal Investigator (Deric C. Savior)
  • Pocono Medical Center, East Stroudsburg, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (J. R. Liu)
  • Saint Luke's Hospital-Anderson Campus, Easton, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Nicholas P. Taylor)
  • Saint Vincent Hospital, Erie, Pennsylvania, United States

  • Lehigh Valley Hospital-Hazleton, Hazleton, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · Morgan_M.Horton@lvhn.org · 610-402-9543
    Contact: Principal Investigator (J. R. Liu)
  • Jefferson Hospital, Jefferson Hills, Pennsylvania, United States

  • Riddle Memorial Hospital, Media, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · turzoe@mlhs.org · 484-476-2649
    Contact: Principal Investigator (Deric C. Savior)
  • Forbes Hospital, Monroeville, Pennsylvania, United States

  • Paoli Memorial Hospital, Paoli, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · turzoe@mlhs.org · 484-476-2649
    Contact: Principal Investigator (Deric C. Savior)
  • Pennsylvania Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · PMCancerResearch@pennmedicine.upenn.edu · 215-349-8245
    Contact: Principal Investigator (Patricia A. Locantore-Ford)
  • Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Mitchell I. Edelson)
  • Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 215-728-4790
    Contact: Principal Investigator (Angela Jain)
  • West Penn Hospital, Pittsburgh, Pennsylvania, United States

  • Saint Luke's Hospital - Upper Bucks Campus, Quakertown, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · 610-776-4714
    Contact: Principal Investigator (Nicholas P. Taylor)
  • Chester County Hospital, West Chester, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · PMCancerResearch@pennmedicine.upenn.edu · 215-349-8245
    Contact: Principal Investigator (Patricia A. Locantore-Ford)
  • Wexford Health and Wellness Pavilion, Wexford, Pennsylvania, United States

  • Asplundh Cancer Pavilion, Willow Grove, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · ONCTrialNow@jefferson.edu · 215-600-9151
    Contact: Principal Investigator (Mitchell I. Edelson)
  • Lankenau Medical Center, Wynnewood, Pennsylvania, United States

    Contact: Study coordinator (Site Public Contact) · turzoe@mlhs.org · 484-476-2649
    Contact: Principal Investigator (Deric C. Savior)
  • Women and Infants Hospital, Providence, Rhode Island, United States

    Contact: Study coordinator (Site Public Contact) · 401-274-1122
    Contact: Principal Investigator (Cara A. Mathews)
  • Smilow Cancer Hospital Care Center - Westerly, Westerly, Rhode Island, United States

    Contact: Study coordinator (Site Public Contact) · canceranswers@yale.edu · 203-785-5702
    Contact: Principal Investigator (Alessandro D. Santin)
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · underberga@sjchs.org · 912-819-5704
    Contact: Principal Investigator (Sarah E. Gill)
  • Medical University of South Carolina, Charleston, South Carolina, United States

    Contact: Study coordinator (Site Public Contact) · hcc-clinical-trials@musc.edu · 843-792-9321
    Contact: Principal Investigator (Brian Orr)
  • Avera Cancer Institute-Aberdeen, Aberdeen, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · oncregulatory@avera.org · 605-622-8700
    Contact: Principal Investigator (David C. Starks)
  • Rapid City Regional Hospital, Rapid City, South Dakota, United States

  • Sanford Cancer Center Oncology Clinic, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicTrialsSF@sanfordhealth.org · 605-312-3320
    Contact: Principal Investigator (Maria C. Bell)
  • Avera Cancer Institute, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncRegulatory@avera.org · 605-322-3095
    Contact: Principal Investigator (David C. Starks)
  • Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota, United States

    Contact: Study coordinator (Site Public Contact) · OncologyClinicalTrialsSF@SanfordHealth.org · 605-312-3320
    Contact: Principal Investigator (Maria C. Bell)
  • The West Clinic - Wolf River, Germantown, Tennessee, United States

  • Dell Seton Medical Center at The University of Texas, Austin, Texas, United States

    Contact: Study coordinator (Site Public Contact) · 512-324-7991
    Contact: Principal Investigator (Marian Y. Williams-Brown)
  • University of Texas at Austin, Austin, Texas, United States

    Contact: Study coordinator (Site Public Contact) · irb@austin.utexas.edu · 512-232-1543
    Contact: Principal Investigator (Marian Y. Williams-Brown)
  • Parkland Memorial Hospital, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-590-5582
    Contact: Principal Investigator (Jayanthi S. Lea)
  • UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Jayanthi S. Lea)
  • Tarrant County Hospital District/JPS Health Network, Fort Worth, Texas, United States

    Contact: Study coordinator (Site Public Contact) · macosta02@jpshealth.org · 817-702-5913
    Contact: Principal Investigator (Gennady Miroshnichenko)
  • UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth, Texas, United States

    Contact: Study coordinator (Site Public Contact) · canceranswerline@UTSouthwestern.edu · 214-648-7097
    Contact: Principal Investigator (Jayanthi S. Lea)
  • Houston Methodist Hospital, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · 713-790-2700
    Contact: Principal Investigator (Aparna A. Kamat)
  • Memorial Hermann Texas Medical Center, Houston, Texas, United States

  • Methodist Willowbrook Hospital, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Aparna A. Kamat)
  • Houston Methodist West Hospital, Houston, Texas, United States

    Contact: Study coordinator (Site Public Contact) · 832-522-2873
    Contact: Principal Investigator (Aparna A. Kamat)
  • Houston Methodist Saint John Hospital, Nassau Bay, Texas, United States

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Aparna A. Kamat)
  • UT Southwestern Clinical Center at Richardson/Plano, Richardson, Texas, United States

    Contact: Study coordinator (Site Public Contact) · Suzanne.cole@utsouthwestern.edu · 972-669-7044
    Contact: Principal Investigator (Jayanthi S. Lea)
  • Houston Methodist Sugar Land Hospital, Sugar Land, Texas, United States

    Contact: Study coordinator (Site Public Contact) · 281-242-2873
    Contact: Principal Investigator (Aparna A. Kamat)
  • Houston Methodist The Woodlands Hospital, The Woodlands, Texas, United States

    Contact: Study coordinator (Site Public Contact) · hmthewoodlands@houstonmethodist.org · 713-790-2700
    Contact: Principal Investigator (Aparna A. Kamat)
  • Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah, United States

    Contact: Study coordinator (Site Public Contact) · cancerinfo@hci.utah.edu · 888-424-2100
    Contact: Principal Investigator (Kristen Kelley)
  • South Jordan Health Center, South Jordan, Utah, United States

    Contact: Study coordinator (Site Public Contact) · cancerinfo@hci.utah.edu · 888-424-2100
    Contact: Principal Investigator (Kristen Kelley)
  • University of Virginia Cancer Center, Charlottesville, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · uvacancertrials@hscmail.mcc.virginia.edu · 434-243-6303
    Contact: Principal Investigator (Kari L. Ring)
  • Henrico Doctor's Hospital, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · 804-591-4152
    Contact: Principal Investigator (Andrew S. Kennedy)
  • VCU Massey Cancer Center at Stony Point, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · ctoclinops@vcu.edu
    Contact: Principal Investigator (Chelsea Salyer)
  • VCU Massey Comprehensive Cancer Center, Richmond, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · CTOclinops@vcu.edu · 804-628-6430
    Contact: Principal Investigator (Chelsea Salyer)
  • Carilion Roanoke Memorial Hospital, Roanoke, Virginia, United States

    Contact: Study coordinator (Site Public Contact) · 540-985-8510
    Contact: Principal Investigator (Chelsea Salyer)
  • Swedish Cancer Institute-Edmonds, Edmonds, Washington, United States

    Contact: Study coordinator (Site Public Contact) · PCRC-NCORP@Swedish.org · 206-215-2343
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Swedish Medical Center-First Hill, Seattle, Washington, United States

    Contact: Study coordinator (Site Public Contact) · PCRC-NCORP@Swedish.org · 206-215-2343
    Contact: Principal Investigator (Dan S. Zuckerman)
  • Legacy Salmon Creek Hospital, Vancouver, Washington, United States

  • West Virginia University Charleston Division, Charleston, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · 304-388-9944
    Contact: Principal Investigator (Stephen H. Bush)
  • West Virginia University Healthcare, Morgantown, West Virginia, United States

    Contact: Study coordinator (Site Public Contact) · cancertrialsinfo@hsc.wvu.edu · 304-293-7374
    Contact: Principal Investigator (Krista S. Pfaendler)
  • Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Seth O. Fagbemi)
  • Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Saint Vincent Hospital Cancer Center at Saint Mary's, Green Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Gundersen Lutheran Medical Center, La Crosse, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · cancerctr@gundersenhealth.org · 608-775-2385
    Contact: Principal Investigator (Kurt Oettel)
  • University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Ellen M. Hartenbach)
  • University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · clinicaltrials@cancer.wisc.edu · 800-622-8922
    Contact: Principal Investigator (Ellen M. Hartenbach)
  • Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Seth O. Fagbemi)
  • Medical College of Wisconsin, Milwaukee, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 414-805-3666
    Contact: Principal Investigator (William H. Bradley)
  • Marshfield Medical Center - Minocqua, Minocqua, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Seth O. Fagbemi)
  • ProHealth D N Greenwald Center, Mukwonago, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · research.institute@phci.org
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Cancer Center of Western Wisconsin, New Richmond, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · mmcorc@healthpartners.com · 952-993-1517
    Contact: Principal Investigator (Jessica A. Thomes Pepin)
  • ProHealth Oconomowoc Memorial Hospital, Oconomowoc, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · 262-928-7878
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Saint Vincent Hospital Cancer Center at Oconto Falls, Oconto Falls, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · WI_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Seth O. Fagbemi)
  • Saint Vincent Hospital Cancer Center at Sheboygan, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Sheboygan Physicians Group, Sheboygan, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Seth O. Fagbemi)
  • Saint Vincent Hospital Cancer Center at Sturgeon Bay, Sturgeon Bay, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · wi_research_admin@hshs.org · 920-433-8889
    Contact: Principal Investigator (Matthew L. Ryan)
  • UW Cancer Center at ProHealth Care, Waukesha, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · Chanda.miller@phci.org · 262-928-5539
    Contact: Principal Investigator (Timothy R. Wassenaar)
  • Marshfield Medical Center - Weston, Weston, Wisconsin, United States

    Contact: Study coordinator (Site Public Contact) · oncology.clinical.trials@marshfieldresearch.org · 800-782-8581
    Contact: Principal Investigator (Seth O. Fagbemi)
  • Centro Comprensivo de Cancer de UPR, San Juan, Puerto Rico

    Contact: Study coordinator (Site Public Contact) · Roster@nrgoncology.org · 412-339-5294
    Contact: Principal Investigator (Luis J. Santos Reyes)
  • Keimyung University-Dongsan Medical Center, Dalseo-gu, Daegu, South Korea

  • Samsung Changwon Hospital, Seoul, Gyeongsangnam-do, South Korea

  • Seoul National University Bundang Hospital, Seongnam, Kyeonggi-do, South Korea

    Contact: Study coordinator (Site Public Contact) · 82-2-2072-2890
    Contact: Principal Investigator (Kidong Kim)
  • Gangnam Severance Hospital, Seoul, South Korea

    Contact: Study coordinator (Site Public Contact) · 82-2-2019-3600
    Contact: Principal Investigator (Jae-Hoon Kim)
Study leads
  • Britt K Erickson

    Principal Investigator

    NRG Oncology